What is dCELL® Technology?

  • Gentle soft tissue decellularization process, removing greater than 99% of DNA and cellular material to reduce risk of rejection and preserve tissue structure.

  • Maintains the natural acellular scaffold of the tissue structure to allow for cellular proliferation, angiogenesis, reduced fibrosis and structural support for pelvic floor procedures.

  • Gentle processing retains strong biomechanical properties in a thin profile making it easy to implant via trans-vaginal, laparoscopic and in robot-assisted surgery.

Learn more about dCELL® Technology

Play Video

DermaPure®, using the patented dCELL® Technology removes >99% of DNA, leaving an intact extracellular matrix.

Not all decellularization and tissue processing are the same...

Tissue with dCELL® Technology is an intact extracellular matrix, with vascular-like channels necessary for revascularization. Retains collagens, proteoglycans,  glycosaminoglycans, as well as other extracellular matrix proteins.

Your patients are looking for new approaches to pelvic floor surgery that avoid the well-known complications of synthetic mesh, the scarring associated with native tissue repairs and the frequent post-surgery follow-up of issues resulting from both methods. Among the human acellular dermis products being used in pelvic floor surgery, there are major differences in decellularization processes.

Competitive technologies leave residual DNA, can damage collagen structures and do not hold up long enough for permanent vasculature and cell development. In contrast, the dCELL® process delivers a “clean slate” with the long-term strength required for full regeneration. DermaPure® sets itself apart from other tissue options and decellularization processes by using the unique and patented dCELL® Technology. The result is lower immunogenicity due to decellularized donor tissue with nearly no structural disruption and near complete removal of donor cells and 99% of donor DNA. 

“The use of decellularized allograft allows for a more thorough repair of a pelvic floor hernia without tension and without artificial materials. In principle, this should decrease the overall recurrence rate of the prolapse and improve the symptoms of perineal laxity without the risk of foreign body erosion.”

Anna M Toker, MD, FACS, FACRS

+ Repair of Internal Rectal Prolapse via Robotic Rectoplexy with DermaPure®

+ Repair of Rectal Prolapse and Pelvic Floor Hernia with DermaPure®

Testimonials

“I wish for more women to be able to experience the amazing recovery that I’ve enjoyed and I am grateful there are clinicians out there like ARMS and products like DermaPure® so women like me can participate in our lives uninhibited and unencumbered by a medical condition. It’s truly been a miracle.”

- Christine V., Patient and Registered Nurse

“When they removed the mesh, the DermaPure® was deployed to completely re-construct my urethra. It’s as if this product also fixed not just the damage mesh had created in my body but also retro repaired with childbirth had done to my urethra and my bladder. It’s truly been a miracle.”

- Christine V., Patient and Registered Nurse

“DermaPure’s® lack of DNA and the presence of decellularized vascular channels for tissue perfusion reduces rejection with decreased inflammation, and the preserved channels facilitate tissue incorporation and healing.”

- Dionysios Veronikis, MD, FACOG, FACS

“The use of decellularized allograft allows for a more thorough repair of a pelvic floor hernia without tension and without artificial materials. In principle, this should decrease the overall recurrence rate of the prolapse and improve the symptoms of perineal laxity without the risk of foreign body erosion.”

- Ana Toker, MD FACS, FACSRS

“In instances such as Stage III prolapse, a biologic implant like DermaPure® allograft is needed to improve the quality of the patient’s native tissue. In my experience, women presenting with Stage III prolapse have attenuated tissue. If they only receive a native tissue repair, they typically will develop a reoccurrence.”

- Manish Patel, M.D, RPh, FACS, FPMRS

“Since learning about DermaPure® from ARMS Medical, I have been very impressed by its advantages over synthetic mesh and competitive biologics. It offers good handling characteristics, is easy to place, incorporates well into surrounding tissue and has a negligible exposure rate. The proprietary dCELL® technology promotes tissue growth and healing more effectively than cross-linked products. I believe in this unique biologic platform and its usefulness in pelvic organ prolapse and mesh removal surgery.”

- James Chivian Lukban, DO, FACOG, FACS, FFPMRS

“DermaPure® was chosen to repair the tissue defect as it provides a firm and elastic tissue support that stimulates the natural healing process and serves as a scaffold upon which host cells can regenerate and differentiate.”

- Ervin Kocjancic MD

“Working closely with ARMS Medical as our provider of specialty pelvic floor surgical solutions, my team had the opportunity to use DermaPure® allograft, along with the Vaginal Retraction System. This solution allowed a minimally invasive vaginal approach for a positive surgical and patient outcome.”

- R. Keith Huffaker, MD, MBA, FACOG, FPMRS

“I have implanted DermaPure® allograft in more than 350 pelvic floor procedures and have had zero complications. In comparison, it’s not unusual for other biologics to cause an initial immune reaction or demonstrate poor healing.”

- Nathan L. Guerette, M.D., FACOG, FAAFP, FPMRS

“I have been looking for a new biologic to replace synthetic mesh in pelvic floor surgery. I learned about DermaPure® human allograft from ARMS Medical and participated in the excellent training they provided. This training included observing anterior and posterior surgical procedures performed by Nathan Guerette, a highly respected urogynecologist. I also learned how the DermaPure® tissue is processed with dCELL® technology.”

- Kenneth Baker, MD

“In our healthcare delivery landscape there’s constant pressure for economic efficiencies. As a surgeon, time is my most precious commodity. Having the VNEW® graft precut into anatomical shapes, and packaged to optimize ease to prepare for suture stabilization saves me significant OR time.”

- Vincent R. Lucente, MD, MBA, FACOG, FPMRS